A 26-year-old female overseas student was admitted to hospital with a fracture of her left humerus following minimal trauma. Biochemical abnormalities included hypercalcaemia, hypophosphataemia, raised alkaline phosphatase, raised parathyroid hormone and undetectable 25-hydroxy-vitamin D. Skeletal X-rays revealed multiple osteolytic lesions in the humerus as well as similar lesions in the femora and pelvis. Magnetic resonance imaging of her left shoulder showed a large soft tissue mass in the proximal humerus. Bone biopsy was reported as consistent with a brown tumour of primary hyperparathyroidism and a sestamibi scan confirmed the presence of a parathyroid adenoma. However, the isotope bone scan was reported as showing features typical of fibrous dysplasia involving multiple sites. The patient subsequently fractured her right femoral shaft, and a femoral nail was inserted. Parathyroidectomy was performed at the same time. Postoperatively she exhibited increased calcium and vitamin D requirements. Coexistence of primary hyperparathyroidism and polyostotic fibrous dysplasia is very rare.
A 26-year-old female overseas student was admitted to hospital with a fracture of her left humerus following minimal trauma. Biochemical abnormalities included hypercalcaemia, hypophosphataemia, raised alkaline phosphatase, raised parathyroid hormone and undetectable 25-hydroxy-vitamin D. Skeletal X-rays revealed multiple osteolytic lesions in the humerus as well as similar lesions in the femora and pelvis. Magnetic resonance imaging of her left shoulder showed a large soft tissue mass in the proximal humerus. Bone biopsy was reported as consistent with a brown tumour of primary hyperparathyroidism and a sestamibi scan confirmed the presence of a parathyroid adenoma. However, the isotope bone scan was reported as showing features typical of fibrous dysplasia involving multiple sites. The patient subsequently fractured her right femoral shaft, and a femoral nail was inserted. Parathyroidectomy was performed at the same time. Postoperatively she exhibited increased calcium and vitamin D requirements. Coexistence of primary hyperparathyroidism and polyostotic fibrous dysplasia is very rare. 2007; 44: 192-195 Case report A 26-year-old female overseas student was admitted to hospital with a fracture of her left humerus. With the help of a translator, the patient said her arm had 'just snapped' when she was opening a car door. She had undergone previous surgery overseas for 'holes in her pelvis' , but no further details of this were available at the time. There was no history of premature menarche or previous fractures; the patient denied taking medications, including over-the-counter or herbal medicines. There was no clear family history of bone disease or malnutrition. Apart from the clinical ¢ndings associated with the fracture, the examination was unremarkable. The patient was of average build and nutrition with a body mass index of 18 kg/m 2 . There was no evidence of hyperpigmentation or skeletal deformities. The colour of the sclerae and teeth were normal. Results of her admission blood tests are shown in Table 1 . The ¢ndings of hypercalcaemia, hypophosphataemia and a raised alkaline phosphatase prompted the addition of analyses that were performed subsequently (parathyroid hormone [PTH] and 25-hydroxy-vitamin D). Hypokalaemia was also noted but spontaneously resolved. X-ray of her humerus showed multiple osteolytic lesions and further X-rays showed similar lesions in the femora and pelvis. Magnetic resonance imaging of her left shoulder (Figure1) showed a large soft-tissue mass in the proximal humerus.
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The humeral fracture was surgically stabilized. At the time of her operation, the di¡erential diagnosis included primary or secondary malignancy of bone, and primary hyperparathyroidism. A core-needle biopsy of her humerus was taken intraoperatively, and further investigations included an isotope bone scan and a sestamibi scan. The bone biopsy was reported as consistent with a brown tumour of primary hyperparathyroidism; this was clearly visualized on the magnetic resonance image of her shoulder. Sestamibi scan subsequently con¢rmed the presence of a right-sided parathyroid adenoma, and the PTH concentration, measured by electrochemiluminescence sandwich immunoassay, was 123 pmol/L (reference range 1.0--6.9) (Roche Diagnostics, Lewes, East Sussex, UK). The isotope bone scan ( Figure 2 ) was reported as showing features typical of ¢brous dysplasia, involving the skull, mandible, pelvis and long bones. Serum 25-hydroxy-vitamin D concentration, measured by chemiluminescent competitive binding assay (Nichols Institute Diagnostics, Heston, Middlesex, UK), was o15 nmol/L (reference range 25--170).
One month later, the patient fractured her right femoral shaft through one of the osteolytic lesions. Parathyroidectomy was planned at the same time as internal ¢xation of the femoral fracture. Preoperatively, the patient was given 1a-hydroxycholecalciferol (Alfacalcidol, 4 mg) and 1,25-dihydroxycholecalciferol (Calcitriol, 2 mg) per day for two days. Parathyroidectomy and femoral nail insertion were performed. Histology of the parathyroid gland con¢rmed the presence of a parathyroid adenoma 12 Â8 Â 4 mm in size, weighing 1.2 g; there were no features of malignancy. Postoperatively, the patient developed hypocalcaemia and hypophosphataemia despite pre and postoperative supplementation ( Table 2) . She was discharged eight days postoperatively on 150 mmol calcium (six Sandocal 1000 tablets) and Calcitriol 1 mg daily, and reviewed in the endocrine outpatient department on two subsequent occasions. At the second appointment (approximately 4 months postparathyroidectomy), she indicated her intention to return home. Oral supplements were discontinued and she was prescribed a single intramuscular injection of Calciferol 300,000 U. She has not returned for review.
Discussion
Several aspects of this case indicate that this patient had unusually severe primary hyperparathyroidism. First, the widespread skeletal changes of osteitis ¢brosa cystica, including the brown tumour seen in her left humerus, are rarely seen today. Coexistent vitamin D de¢ciency may contribute to the severity of the skeletal lesions. 1 In addition, there is experimental evidence that elevated PTH secretion may be implicated in the enhanced degradation of 25-hydroxy-vitamin D. 2 Second, it is unusual for primary hyperparathyroidsim to present with a fracture, although the possible coexistence of ¢brous dysplasia complicates the attribution of this clinical presentation. Third, the patient developed hypocalcaemia and hypophosphataemia after the parathyroidectomy despite pre and postoperative supplementation. This is consistent with hungry bone syndrome, where demineralized bones rapidly absorb calcium and phosphate once pathological stimulation of bone resorption has been removed. 3 Because of these features, and the relatively young age of the patient, active consideration was given to the possibility of parathyroid carcinoma and/or coexistence of other features of multiple endocrine neoplasia. However, histology of the parathyroid gland did not reveal any evidence of malignancy, and phenotypic (biochemical) screening did not support a diagnosis of multiple endocrine neoplasia (Table 3 ).
An isotope bone scan, the most sensitive imaging technique for the detection of ¢brous dysplasia, showed features typical of that condition. Fibrous dysplasia of bone is a condition in which areas of immature ¢brous tissue are found within the skeleton. It arises from activating mutations in the GNAS1 gene (guanine nucleotide-binding a subunit), which encodes a stimulatory G protein involved in cell signalling. 4 These mutations occur in somatic cells, only some of which are a¡ected, resulting in genetic mosaicism. The degree of mosaicism determines the proportion and distribution of cells that carry the mutation and hence the areas of bone involved. The disease is classically described as monostotic or polyostotic, depending on the number of bones a¡ected. The polyostotic form is sometimes associated with patches of cafe Ł -au-lait pigmentation of the skin and one or more hyperfunctioning endocrinopathies (the McCune--Albright syndrome). 5 In one series of 35 cases of polyostotic ¢brous dysplasia (PFD), 27 had the McCune--Albright syndrome; the endocrinopathies included precocious puberty (19 cases), hyperthyroidism (9 cases), growth hormone excess (6 cases) and one patient each with Cushing's disease and hyperparathyroidism. 6 The diagnosis of PFD here rests largely on the ¢ndings of the isotope bone scan, as the humeral biopsy did not reveal features of PFD and the femur was not biopsied. However, femoral fracture is a classical feature of PFD. More detailed information about the patient's previous medical history subsequently became available and indicated that doctors overseas had diagnosed 'pantosomatous multiple dysplasia of bone ¢bre' (sic) based on biopsy of her left ileum. It is di⁄cult to know what weight to attach to this. The role of radionuclide bone scintigraphy in ¢brous dysplasia has been reviewed. 7 Certain features seen in Figure 2 are characteristic of PFD. It tends to involve the extremities and ribs; other a¡ected sites include the spine and scapulae. Such an extensive distribution is not usually seen in primary hyperparathyroidism. Other di¡erential diagnoses include metastatic disease and Paget's disease of bone. However, there were no other clinical or radiological features here to support either of these alternative diagnoses.
Coexistence of primary hyperparathyroidism and PFD is very rare. In one series of 350 cases of primary hyperparathyroidism, collected over two decades, only two cases were proven to have coexistent ¢brous dysplasia. 8 If she did have both conditions, did they occur independently of each other, or together as part of the McCune--Albright syndrome (dual or single pathology)? The PFD lesions in McCune--Albright syndrome have been reported to be very sensitive to the e¡ects of PTH, 9 especially when there is coexistent vitamin D de¢ciency. There were no other features of the McCune--Albright syndrome (pigmentation, clear history of precocious puberty), but not all features are present in every case. However, without the patient's informed consent, we are not in a position to test for the GNAS1 mutation in the humeral biopsy. Follow-up isotope bone scan might help to establish the relative contributions of each condition to this patient's metabolic bone disease, if the changes due to hyperparathyroidism are resolved; but this has not been possible to date. In short, this issue is unresolved at the time of writing; the patient is currently lost to follow-up. 
